Evidence map›Paper›PMID 41659358›Full record

ArticleNature health2026

A community-codesigned LLM-powered chatbot for primary care: a randomized controlled trial.

Sairan Li, Yanzeng Li, Shuya Zhou, Xinge Tao, Changjie Yu, Muzi Shen, Wangyue Chen, En Meng, Boyou Wu, Qirui Huang and 5 more

Abstract read
In one paragraph

Article in Nature health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Moving past size in nanoplastics research.Nature nanotechnology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sairan Li *School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yanzeng Li *Institute of Artificial Intelligence and Future Networks, Beijing Normal University, Zhuhai, China.ORCID 0000-0003-4880-5804
Shuya ZhouSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinge TaoSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0009-0006-8548-6733
Changjie YuNational Research Institute for Family Planning, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Muzi ShenSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wangyue ChenSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
En MengSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Boyou WuSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qirui HuangSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Frances S MairSchool of Health and Wellbeing, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0001-9780-1135
Jinchao ZhangPattern Recognition Center, WeChat AI, Tencent Inc., Beijing, China.ORCID 0000-0003-4611-9675
Jie ZhouPattern Recognition Center, WeChat AI, Tencent Inc., Beijing, China.ORCID 0000-0002-5899-5165
Lei ZouWangxuan Institute of Computer Technology, Peking University, Beijing, China.ORCID 0000-0002-8586-4400
Shasha HanSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-7388-8125

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With a global shortage of primary healthcare physicians-particularly in resource-limited settings-large language models (LLMs) have the potential to support and enhance patients' health awareness. Here we developed P&P Care (Population Medicine and Public Health), an LLM-powered primary care chatbot using a dual-track role-play codesign framework where community stakeholders and researchers simulated each another's perspectives across four phases: contextual understanding; cocreation; testing and refinement; and implementation and evolution. The codesigned chatbot was integrated with e-learning modules and tested in a randomized controlled trial. The trial included 2,113 participants (1,052 women and 1,061 men) from urban and rural areas across 11 Chinese provinces who were randomly assigned to receive a consultation either with preparatory e-learning via the P&P Care or without. The study met its primary endpoint with the e-learning group showing significantly higher objective health awareness (mean score 2.95 ± 1.22) compared with the consultation-only group (mean score 2.34 ± 1.02;

Indexed as

Health servicesPublic healthRandomized controlled trialsTranslational research

Identifiers

PMID41659358
PMCPMC12880911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.